This work was produced by Edwards et al. under the terms of a commissioning contract issued by the Secretary of State for Health and Social Care. This is an Open Access publication distributed under the terms of the Creative Commons Attribution CC BY 4.0 licence, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. See: https://creativecommons.org/licenses/by/4.0/. For attribution the title, original author(s), the publication source – NIHR Journals Library, and the DOI of the publication must be cited.
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Edwards SJ, Karner C, Jhita T, et al. Abrocitinib, tralokinumab and upadacitinib for treating moderate-to-severe atopic dermatitis. Southampton (UK): National Institute for Health and Care Research; 2024 Jan. (Health Technology Assessment, No. 28.04.)
Abrocitinib, tralokinumab and upadacitinib for treating moderate-to-severe atopic dermatitis.
Show detailsThis monograph is based on the Multiple Technology Assessment Report produced for National Institute for Health and Care Excellence (NICE). The full report contained a considerable number of data that were deemed confidential and were used by the Advisory Committee at NICE in their deliberations. The full version of the report with the confidential information removed is available on the NICE website: www.nice.org.uk.
The present monograph presents as full a version of the report as is possible while retaining readability, but some sections, sentences, tables and figures have been removed. Readers should bear in mind that the discussion, conclusions and implications for practice and research are based on all the data considered in the original full NICE report.
- Note about the research - Abrocitinib, tralokinumab and upadacitinib for treatin...Note about the research - Abrocitinib, tralokinumab and upadacitinib for treating moderate-to-severe atopic dermatitis
- Maytenus rigida 18S ribosomal RNA gene, partial sequence; internal transcribed s...Maytenus rigida 18S ribosomal RNA gene, partial sequence; internal transcribed spacer 1, 5.8S ribosomal RNA gene, and internal transcribed spacer 2, complete sequence; and 28S ribosomal RNA gene, partial sequencegi|345546913|gb|HQ267190.1|Nucleotide
Your browsing activity is empty.
Activity recording is turned off.
See more...